Previous Close | 33.69 |
Open | 33.67 |
Bid | 34.21 x N/A |
Ask | 34.31 x N/A |
Day's Range | 33.60 - 36.46 |
52 Week Range | 9.57 - 43.81 |
Volume | |
Avg. Volume | 3,091 |
Market Cap | 4.356B |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.40 |
Earnings Date | Aug 29, 2023 - Sep 04, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 73.33 |
Fool.com contributor and finance professor Parkev Tatevosian discusses what a big update from C3.ai (NYSE: AI) management means for investors. The news has implications that might change your mind about C3.
C3.ai had sales of $72.4 million in the fiscal fourth quarter--in line with the higher end of its preliminary sales numbers.
C3.ai (NYSE: AI) has been one of the biggest winners on the stock market this year, riding the surge of investor interest in all things artificial intelligence (AI). The stock fell 13% after it reported fiscal fourth-quarter earnings on May 31 as it offered tepid guidance for fiscal 2024, but one Wall Street analyst was singing the company's praises. Wedbush's Dan Ives upgraded the stock on June 1 from neutral to outperform and raised his price target on the stock from $24 to $50.
The major test for C3.ai will be how well the business does in the current fiscal year now that artificial intelligence (AI) is at the forefront of many investors' minds, and companies of all kinds are showing an interest in it. While this would not be true profitability based on generally accepted accounting principles (GAAP), it would still mean that C3.ai is improving its financials. True accounting profitability likely won't be attainable this fiscal year.
Fool.com contributor and finance professor Parkev Tatevosian looks deeper into C3.ai's (NYSE: AI) business prospects to understand why everyone is talking about the artificial intelligence stock right now.
AI investments may be hot, but the VC space overall remains noticeably cool, recent Crunchbase data shows.
Artificial intelligence (AI) is all the rage, but not every company developing AI-related products and services deserves your investment dollars. Enterprise AI software vendor C3.ai (NYSE: AI) and AI lending marketplace Upstart (NASDAQ: UPST) are both posting big losses, and neither are seeing huge upticks in demand amid the AI boom. While shares of enterprise AI software provider C3.ai have shot up this year, the business itself hasn't done nearly as well.
Or should investors avoid the hype? C3.ai makes plug-in AI applications for clients in many different industries. While the company has products in multiple industries, including manufacturing, defense, financial services, and healthcare, most of its business comes from oil and gas.
Analysts, however, were looking for a slightly stronger jump of 19% to $317 million, and C3.ai's failure to hit that mark sent the stock packing. Meanwhile, the company expects the non-GAAP loss from operations to range between $50 million and $75 million in fiscal 2024, which points toward a slight improvement at the midpoint when compared to fiscal 2023's reading of $68 million.
There is a disconnect between the hype and how it is going to ensure a sustainable source of revenue
Fool.com contributor and finance professor Parkev Tatevosian looks at C3.ai's (NYSE: AI) latest conference call to get an overview of what's happening at the AI company. *Stock prices used were the afternoon prices of June 5, 2023.
Goldman makes a big markets call based on the rising popularity of AI stocks.
Investors continue to gauge the potential of Apple's new Vision Pro VR headset announced at its Worldwide Developers Conference. Wedbush Managing Director and Senior Equity Analyst Dan Ives sits down with Yahoo Finance Live to explain why this headset could be a good move for Apple, C3.ai's position in the artificial intelligence space, and Tesla's driverless technology.
Yahoo Finance tech reporter Allie Garfinkle breaks down Spruce Point Capital Management's latest note critiquing artificial intelligence developer C3.ai and its leadership as the company finds itself at the center of the AI hype bubble. Yahoo Finance Live interviewed Spruce Point Capital Founder Ben Axler earlier this week.
Companies are racing to find ways they can integrate artificial intelligence (AI) into their products, services, and general operations right now, because it's becoming clear the technology is capable of boosting productivity and reshaping customer experiences. Tools like OpenAI's online chatbot ChatGPT are capable of holding deep conversations with users on complex topics, and they can even write computer code to supercharge the development of software applications. Ark Investment Management, run by famed technology investor Cathie Wood, is one of the most bullish firms on Wall Street when it comes to AI.
Here’s some of the stocks currently dominating developments in artificial intelligence in 2023.
C3.ai shares have been riding the AI wave. But not everyone is happy with its performance. Spruce Point Capital Management Founder and CIO Ben Axler, a short-seller, has written an open letter to one of the company's directors questioning the company's business. Axler explains his concerns to Yahoo Finance Live's Seana Smith and Allie Garfinkle.
C3.ai, Inc. (AI) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
It's time to call out some trends to watch in the stock market before hitting the surf and sand.
For the fourth quarter of its fiscal 2023, which ended on April 30, the artificial intelligence (AI) enterprise software company's revenue stayed nearly flat year over year at $72.4 million, but still surpassed analysts' expectations by $1 million. The company narrowed its adjusted net loss from $22.6 million in the year-ago period to $15.2 million, or $0.13 per share, which cleared the consensus forecast by $0.04 per share. For the full fiscal year, C3.ai's revenue rose 6% to $266.8 million as it narrowed its adjusted net loss from $76.7 million to $46.4 million, or $0.42 per share.
Late last month, shares in Nvidia (NASDAQ:NVDA) hit a new milestone. Thanks to the chipmaker’s post-earnings rally, NVDA stock entered “trillion dollar territory” for the first time. After climbing to prices above $404.85 per share, Nvidia’s market cap reached the $1 trillion mark. However, it is unclear right now whether NVDA is now a permanent member of the “trillion dollar club,” or if the stock merely holds a guest membership. Since hitting this milestone, profit-taking has caused the stock
When it comes to stock investing, learning should come before buying, not the other way around. Unfortunately, some financial traders are jumping headlong into C3.ai (NYSE:AI) stock because they’ve been told that artificial intelligence is a red-hot trend now. It’s fine to own a moderately sized share position in C3.ai if that’s what you want to do. However, it’s important to know why you’re investing in this particular machine learning company. There’s no denying that machine learning is top-of
The company sells its AI application-development platform and its suite of AI applications to large enterprises, which means long sales cycles and hefty spending on sales and marketing. Revenue was unchanged from the prior-year period, net loss worsened, and the company guided for a sequential revenue decline in the first quarter of fiscal 2024. Despite this increased interest, the company expects sluggish revenue growth in fiscal 2024.
During a banner month for AI stocks, C3.ai (NYSE: AI) was among the big winners, jumping a whopping 125%, according to data from S&P Global Market Intelligence. C3.ai stock, which has been volatile all year, jumped on a better-than-expected preliminary earnings report; it concluded its short-seller investigation without finding any wrongdoing and got another tailwind when Nvidia gave much better guidance than expected for the second quarter, showing investors that demand for AI chips is soaring. Most of the stock's gains in the second half of the month after the earnings report, and it then soared following the Nvidia news.
We are initiating coverage of Kenvue with an Overweight rating and a December 2023 price target of $29. As the largest pure-play consumer health company in the world following its separation from parent Johnson & Johnson, Kenvue is uniquely positioned to benefit from consumer megatrends (self-care, aging). As a stand-alone company, we believe that Kenvue’s board and management will be more focused and accountable for the growth and profitability of the business following the separation that began in 2019, with significant opportunities to scale.